Holly RUMERY, Research  Development  - InnOvOtionByHolly  - Owner founder

Holly RUMERY

Research Development

InnOvOtionByHolly

Owner founder

LINCOLN, NE | United States

Main Specialties: Allergy & Immunology, Biochemical Genetics, Biology, Biotechnology, Blood Banking - Transfusion Medicine, Child Neurology, Clinical & Laboratory Immunology, Emergency Medicine, Infectious Disease, Medical Genetics, Oncology, Preventive Medicine, Public Health

Additional Specialties: Project management

ORCID logohttps://orcid.org/0000-0002-2688-8592


Top Author

Holly RUMERY, Research  Development  - InnOvOtionByHolly  - Owner founder

Holly RUMERY

Research Development

Education

Sep 2018
Berkley University
Extraterrestrial study
Sep 2005
Tyler junior college
ROTC

Experience

Dec 2011
NASA Ames Research Center
Host /Project Leader / humanitarians activist
ImmunoTherapy /Immunogobulin medicine and science innovation and discovery
Dec 2011
University of California Berkeley
Extraterestrial studys BioMedical agricuture engieering
Seti@home Einstien@home Rosetta@home
InnOvOtion by Holly
Bioengineering
RNA world

Publications

159Publications

3263Reads

1155Profile Views

452PubMed Central Citations

Biomedical research InnOvOtion by Holly

Authors:
Holly Rumery

InnOvOtion by Holly

https://documentcloud.adobe.com/link/track?uri=urn%3Aaaid%3Ascds%3AUS%3A078d880e-4cef-4ed6-90a0-64a309d93948

View Article
January 2019

Stop Terrorizem Over Phishing

Authors:
Holly rumery

InnOvOtion by Holly



Crispr 9

View Article
January 2019

Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.

Mol Carcinog 2018 Dec 21. Epub 2018 Dec 21.

Department of Pathology, School of Medicine, Molecular Biology Program, Medical Scientist Training Program, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22958DOI Listing
December 2018
6 Reads
4.808 Impact Factor

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.

J Thorac Oncol 2018 Oct 20;13(10):1474-1482. Epub 2018 Jun 20.

Department of Medicine - Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286810PMC
October 2018
33 Reads
1 Citation
5.282 Impact Factor

Citizenship

Authors:
Holly Rumery

InnOvOtionByHolly

https://drive.google.com/file/d/1kDoiJ7quHhe3G5TctLtwMKHL4fqYcDhU/view?usp=drivesdk

View Article
September 2018
26 Reads

Resistance Mechanisms to Targeted Therapies in and Non-small Cell Lung Cancer.

Clin Cancer Res 2018 Jul 10;24(14):3334-3347. Epub 2018 Apr 10.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050099PMC
July 2018
28 Reads
1 Citation
8.722 Impact Factor

Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases.

J Oral Pathol Med 2018 Feb 27;47(2):192-197. Epub 2017 Nov 27.

Division of Medical Oncology and University of Colorado Cancer Center, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jop.12658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157737PMC
February 2018
15 Reads
1.870 Impact Factor

EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study.

J Thorac Oncol 2018 02 20;13(2):228-236. Epub 2017 Nov 20.

Division of Medical Oncology, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.11.109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233716PMC
February 2018
14 Reads
5.282 Impact Factor

Biomarker Testing for Personalized Therapy in Lung Cancer in Low- and Middle-Income Countries.

Am Soc Clin Oncol Educ Book 2017 ;37:403-408

From the University of Colorado School of Medicine, University of Colorado Cancer Center, International Association for the Study of Lung Cancer, Aurora, CO; Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad, Sremska Kamenica, Serbia; National Cancer Institute, Cairo University, Giza, Egypt; Chiang Mai University, Chiang Mai, Thailand; Pathology Department, Chiang Mai University, Chiang Mai, Thailand; Hospital Italiano Buenos Aires, Perón, Argentina; University of Colorado Anschutz Medical Campus, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EDBK_175243DOI Listing
December 2017
16 Reads

Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer.

J Thorac Oncol 2017 10 19;12(10):1512-1523. Epub 2017 Jun 19.

Department of Medicine, Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado; Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647865PMC
October 2017
29 Reads
5.282 Impact Factor

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

J Mol Diagn 2017 09 9;19(5):682-696. Epub 2017 Aug 9.

Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975628PMC
September 2017
43 Reads
4.851 Impact Factor

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 07 6;12(7):e85-e88. Epub 2017 Mar 6.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.020DOI Listing
July 2017
5 Reads
5.282 Impact Factor

MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme.

PLoS One 2016 26;11(10):e0165107. Epub 2016 Oct 26.

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA, 30322, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165107PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081168PMC
June 2017
16 Reads
3.234 Impact Factor

Responses to Crizotinib Can Occur in High-Level MET-Amplified Non-Small Cell Lung Cancer Independent of MET Exon 14 Alterations.

J Thorac Oncol 2017 01 21;12(1):141-144. Epub 2016 Sep 21.

Clinical Oncology, Cancer Institute of the State of São Paulo, School of Medicine, University of São Paulo, São Paulo, Brazil; Sírio Libanês Hospital, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.09.116DOI Listing
January 2017
13 Reads
5.282 Impact Factor

An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.

J Thorac Oncol 2016 12 6;11(12):2248-2252. Epub 2016 Sep 6.

University Health Network, Ontario Cancer Institute/Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573599PMC
December 2016
22 Reads
5.282 Impact Factor

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.

J Thorac Oncol 2016 08 9;11(8):1273-1281. Epub 2016 Apr 9.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961521PMC
August 2016
91 Reads
5.282 Impact Factor

Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis.

J Thorac Oncol 2016 08 1;11(8):1293-1304. Epub 2016 Jun 1.

University of Colorado School of Medicine, Division of Medical Oncology, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404374PMC
August 2016
12 Reads
5.282 Impact Factor

Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord.

PLoS One 2015 15;10(9):e0137690. Epub 2015 Sep 15.

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; 3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137690PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570813PMC
May 2016
20 Reads
3.234 Impact Factor

Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?

J Cancer 2016 20;7(6):633-49. Epub 2016 Mar 20.

3. Department of Medicine, University of Colorado, Anschutz Medical Campus, 12801 East 17th Ave, RC1 South, L18-8118, Mail Stop 8117, Aurora, Colorado, USA 80045.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.12663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829549PMC
April 2016
7 Reads
2.639 Impact Factor

De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue.

FASEB J 2016 Mar 18;30(3):1096-108. Epub 2015 Nov 18.

*Division of Geriatric Medicine, Division of Medical Oncology, and Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, School of Medicine, Flow Cytometry Shared Resource, Molecular Pathology/Cytogenetics Shared Resource, University of Colorado Cancer Center, Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, and Colorado Obesity Research Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA; Molecular Diagnostic Laboratory, Children's Hospital Colorado, Aurora, Colorado, USA; and Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, and **Center for Stem Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.15-278994DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750419PMC
March 2016
37 Reads
5.043 Impact Factor

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

J Thorac Oncol 2016 Mar 24;11(3):414-9. Epub 2015 Dec 24.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698879PMC
March 2016
55 Reads
5.282 Impact Factor

Waxing and Waning of MET Amplification in EGFR-Mutated NSCLC in Response to the Presence and Absence of Erlotinib Selection Pressure.

J Thorac Oncol 2015 Dec;10(12):e115-8

Division of Medical Oncology, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000642DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693630PMC
December 2015
3 Reads
5.282 Impact Factor

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.

J Neuropathol Exp Neurol 2015 Jul;74(7):743-54

From the Molecular Oncology Research Center (APB, ACC, AP, RMR), and Department of Pathology (CSN), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Cancer Center (JS, DLA), and School of Medicine (EM, MVG), University of Colorado, Aurora, Colorado; Department of Neurosurgery(CC), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Surgery (RSO), and Department of Pathology and Forensic Medicine (APB, LN), Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP), São Paulo, Brazil; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho (RMR), Braga, Portugal; and ICVS/3B's - PT Government Associate Laboratory(RMR), Braga/Guimarães, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0000000000000213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470527PMC
July 2015
12 Reads
3.797 Impact Factor

Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.

J Thorac Oncol 2015 Jul;10(7):1083-90

*Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, Shanghai, People's Republic of China; †Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ‡Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland; §Institute of Pathology, University Hospital Cologne, Medical Centre, Cologne, Germany; ‖Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, Colorado; ¶Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado; and #Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000562DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467588PMC
July 2015
32 Reads
5.282 Impact Factor

Macrothrombocytopenia as diagnosis predictor of 22q11 deletion syndrome among patients with congenital heart defects.

Am J Med Genet A 2015 Jun 21;167(6):1406-8. Epub 2015 Apr 21.

Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajmg.a.36531
Publisher Site
http://dx.doi.org/10.1002/ajmg.a.36531DOI Listing
June 2015
9 Reads
2.159 Impact Factor

MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.

Am J Clin Oncol 2015 Apr;38(2):152-8

*Department of Medical Oncology, S. Maria della Misericordia Hospital Departments of †Electronic and Information Engineering ‡Thoracic Surgery §Institute of Pathological Anatomy and Histology, University of Perugia, Perugia, Italy ∥Department of Medicine/Medical Oncology, University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607281PMC
April 2015
8 Reads
2.611 Impact Factor

Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.

Ther Adv Med Oncol 2015 Mar;7(2):56-62

Department of Hematology and Medical Oncology, Emory University School of Medicine, 1365 Clifton Road, NE, Room C3080, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1758834014567117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346214PMC
March 2015
20 Reads

Congenital heart disease in Southern Brazil: potential impact and prevention.

Int J Cardiol 2015 Jan 1;179:9-10. Epub 2014 Nov 1.

Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), RS, Brazil; Clinical Genetics, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) and Complexo Hospitalar Santa Casa de Porto Alegre (CHSCPA), RS, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2014.10.052DOI Listing
January 2015
7 Reads
4.036 Impact Factor

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

N Engl J Med 2014 Nov 27;371(21):1963-71. Epub 2014 Sep 27.

From the Massachusetts General Hospital Cancer Center (A.T.S., L.P.L., Z.Z., J.W.C., A.J.I.), Dana-Farber Cancer Institute (G.I.S.), and Beth Israel Deaconess Medical Center (D.B.C.) - all in Boston; University of California at Irvine, Irvine (S.-H.I.O.), and Pfizer Oncology, La Jolla (W.T., S.M.S., L.M.T., J.G.C., K.D.W.) - both in California; Seoul National University Hospital, Seoul, South Korea (Y.-J.B.); University of Colorado, Aurora (D.R.C., M.V.-G., R.C.D.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); University of Chicago, Chicago (R.S.); Memorial Sloan Kettering Cancer Center, New York (G.J.R.); Karolinska Institutet, Stockholm (Z.Z.); and Rho, Chapel Hill, NC (P.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1406766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264527PMC
November 2014
49 Reads
55.873 Impact Factor

Role of hypocalcemia in identification of 22q11 deletion syndrome among patients with congenital heart defects.

Int J Cardiol 2014 Nov 5;177(1):6-7. Epub 2014 Oct 5.

Clinical Genetics, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) and Complexo Hospitalar Santa Casa de Porto Alegre (CHSCPA), RS, Brazil; Graduate Program in Pathology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), RS, Brazil; Clinical Genetics, Hospital Materno Infantil Presidente Vargas (HMIPV), RS, Brazil. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2014.09.133DOI Listing
November 2014
20 Reads
4.036 Impact Factor

Screening for 22q11 deletion syndrome among patients with congenital heart defects.

Sao Paulo Med J 2014 ;132(2):125-6

Complexo Hospitalar Santa Casa de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116674PMC
October 2014
6 Reads
1 Citation
0.703 Impact Factor

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.

PLoS One 2013 13;8(12):e82236. Epub 2013 Dec 13.

Department of Medicine, Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0082236PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862576PMC
October 2014
20 Reads
3.234 Impact Factor

Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignancies.

Clin Cancer Res 2014 Mar 3;20(6):1656-65. Epub 2014 Feb 3.

Authors' Affiliations: Department of Medicine, Division of Medical Oncology; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado; and Onconova Therapeutics Inc, Newtown, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2506DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160109PMC
March 2014
21 Reads
8.722 Impact Factor

Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer.

J Thorac Oncol 2014 Mar;9(3):e21-3

*Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, People's Republic of China; †Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado; and ‡Department of Pathology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153022
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117236PMC
March 2014
13 Reads
14 Citations
5.282 Impact Factor

ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.

Mol Cancer Res 2014 Jan 2;12(1):111-8. Epub 2013 Dec 2.

University of Colorado School of Medicine Anschutz Medical Campus, 12801 East 17th Avenue, L18-8118, Mail Stop 8117, Aurora, CO 80045.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-13-0479-TDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140177PMC
January 2014
30 Reads
4.380 Impact Factor

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.

Cancer 2013 Apr 20;119(8):1467-77. Epub 2012 Dec 20.

Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935240PMC
April 2013
5 Reads
4.889 Impact Factor

[22q11.2 deletion syndrome and complex congenital heart defects].

Rev Assoc Med Bras (1992) 2011 Jan-Feb;57(1):62-5

Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS.

View Article

Download full-text PDF

Source
March 2013
5 Reads
0.915 Impact Factor

Diphtheria toxin-epidermal growth factor fusion protein DAB389EGF for the treatment of bladder cancer.

Clin Cancer Res 2013 Jan 21;19(1):148-57. Epub 2012 Nov 21.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537889PMC
January 2013
11 Reads
8.722 Impact Factor

Oncogenic fusions involving exon 19 of ALK.

J Thorac Oncol 2012 Dec;7(12):e44

Department of Medicine, Division of Medical Oncology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826bb94dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963141PMC
December 2012
3 Reads
5.282 Impact Factor

Malformations detected by abdominal ultrasound in children with congenital heart disease.

Arq Bras Cardiol 2012 Dec 30;99(6):1092-9. Epub 2012 Nov 30.

Programa de Pós-graduação em Patologia, Fundação Universidade Federal de Ciências da Saúde de Porto Alegre, RS, Brasil.

View Article

Download full-text PDF

Source
December 2012
5 Reads
1.124 Impact Factor

Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer.

Cancer 2012 Sep 26;118(18):4502-11. Epub 2012 Jan 26.

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370097PMC
September 2012
26 Reads
4.889 Impact Factor

Biologic and genetics aspects of chagas disease at endemic areas.

J Trop Med 2012 8;2012:357948. Epub 2012 Mar 8.

Department of Especial Education, UNESP São Paulo State University, 17525-900 Campus Marília, SP, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/357948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317048PMC
August 2012
18 Reads

Prognostic patterns in the histopathology of pulmonary adenocarcinoma.

J Clin Oncol 2012 May 5;30(13):1401-3. Epub 2012 Mar 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.3964DOI Listing
May 2012
9 Reads
18.428 Impact Factor

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

Clin Cancer Res 2012 Mar 10;18(5):1472-82. Epub 2012 Jan 10.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80209, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311875PMC
March 2012
19 Reads
8.722 Impact Factor

Anterior laryngeal membrane and 22q11 deletion syndrome.

Braz J Otorhinolaryngol 2011 Jul-Aug;77(4):540

CHSCPA, UFCSPA, Brazil.

View Article

Download full-text PDF

Source
February 2012
3 Reads

HIV-1 Tat increases oxidant burden in the lungs of transgenic mice.

Free Radic Biol Med 2011 Nov 5;51(9):1697-707. Epub 2011 Aug 5.

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.freeradbiomed.2011.07.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188365PMC
November 2011
3 Reads
5.736 Impact Factor

Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.

Urology 2011 Oct 2;78(4):863-7. Epub 2011 Aug 2.

Department of Medicine, University of Colorado, School of Medicine, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2011.05.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190033PMC
October 2011
6 Reads
2.188 Impact Factor

Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.

Clin Cancer Res 2011 Apr 21;17(8):2434-43. Epub 2011 Jan 21.

Departmentsof Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-1412DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078948PMC
April 2011
17 Reads
8.722 Impact Factor

Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed.

J Thorac Oncol 2011 Apr;6(4):774-80

Department of Medical Oncology, University of Colorado Denver, 1665 North Ursula Street, Room 2256, P.O. Box 6510, Mail Stop F-706, Aurora, CO 80045-0508, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31820cf053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626562PMC
April 2011
10 Reads
5.282 Impact Factor

Finding ALK-positive lung cancer: what are we really looking for?

J Thorac Oncol 2011 Mar;6(3):411-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31820cf068DOI Listing
March 2011
3 Reads
5.282 Impact Factor

Suppression of leukemia development caused by PTEN loss.

Proc Natl Acad Sci U S A 2011 Jan 6;108(4):1409-14. Epub 2011 Jan 6.

Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/content/108/4/1409.full.pdf
Web Search
http://www.pnas.org/cgi/doi/10.1073/pnas.1006937108
Publisher Site
http://dx.doi.org/10.1073/pnas.1006937108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029702PMC
January 2011
27 Reads
9.809 Impact Factor

Optimizing the detection of lung cancer patients harboring anaplastic lymphoma kinase (ALK) gene rearrangements potentially suitable for ALK inhibitor treatment.

Clin Cancer Res 2010 Nov 9;16(22):5581-90. Epub 2010 Nov 9.

Division of Medical Oncology and Department of Pathology, University of Colorado-Denver, 1665 North Ursula Street, Aurora, CO 80045-0508, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-0851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395226PMC
November 2010
6 Reads
8.722 Impact Factor

[Oculo-auriculo-vertebral spectrum in patients with congenital heart defects].

Arq Bras Cardiol 2010 Oct 3;95(4):436-9. Epub 2010 Sep 3.

Universidade Federal de Ciências da Saúde de Porto Alegre.

View Article

Download full-text PDF

Source
October 2010
6 Reads
1.124 Impact Factor

De novo generation of white adipocytes from the myeloid lineage via mesenchymal intermediates is age, adipose depot, and gender specific.

Proc Natl Acad Sci U S A 2010 Aug 2;107(33):14781-6. Epub 2010 Aug 2.

Charles C Gates Regenerative Medicine and Stem Cell Biology Program, Department of Pediatrics, Cardiovascular Pulmonary Research Laboratory, University of Colorado, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1003512107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930432PMC
August 2010
14 Reads
9.809 Impact Factor

Top co-authors

Dara L Aisner
Dara L Aisner

University of Colorado Cancer Center

27
Robert C Doebele
Robert C Doebele

University of Colorado

24
Wilbur A Franklin
Wilbur A Franklin

University of Colorado

14
Fred R Hirsch
Fred R Hirsch

University of Colorado Cancer Center

13
Anh T Le
Anh T Le

School of Economics and Finance

12
Antonio Jimeno
Antonio Jimeno

University of Colorado Cancer Center

10
Paul A Bunn
Paul A Bunn

University of Colorado Cancer Center

8
Wells A Messersmith
Wells A Messersmith

University of Colorado Cancer Center

8